Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure
- 31 March 2005
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42 (3), 350-357
- https://doi.org/10.1016/j.jhep.2004.11.019
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Fulminant liver diseaseClinics in Liver Disease, 2003
- Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United StatesAnnals of Internal Medicine, 2002
- Accelerated reversal of carbon tetrachloride‐induced cirrhosis in rats by the endothelin receptor antagonist TAK‐044Journal of Gastroenterology and Hepatology, 2002
- Acute liver failure: Targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failureJournal of Hepatology, 2000
- Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.JCI Insight, 1998
- Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistanceHepatology, 1996
- Liver cell necrosis: Cellular mechanisms and clinical implicationsGastroenterology, 1995
- Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbancesHepatology, 1994
- Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Effects of cytokines on the liverHepatology, 1991